Difficulty: Medium
Average Score: 75%
Practice
The nurse is discharging five Rh-negative clients from the maternity unit. The nurse knows that the teaching was successful when the client who had which of the following deliveries asks why she must receive a RhoGAM injection? Select one that doesn't apply
Correct answer
D
Rationale
The correct answer is D) Birth of Rh-negative twins at 35 weeks' gestation. In this scenario, the client delivered Rh-negative twins, which means there is no risk of Rh incompatibility as both babies lack the Rh antigen. Therefore, there is no need for RhoGAM injection in this situation.
Option A) Abortion at 10 weeks' gestation: In an abortion at 10 weeks' gestation, there is a risk of fetal-maternal hemorrhage, leading to the exposure of the Rh antigen to an Rh-negative mother, necessitating RhoGAM administration.
Option B) Amniocentesis at 16 weeks' gestation: Amniocentesis can lead to the mixing of fetal and maternal blood, increasing the risk of sensitization in an Rh-negative mother. RhoGAM is required in this situation to prevent Rh sensitization.
Option C) Fetal demise at 24 weeks' gestation: In cases of fetal demise, there is a potential for fetal-maternal hemorrhage, exposing the mother to the Rh antigen. RhoGAM is administered to prevent Rh sensitization in this scenario.
Educational context: Understanding the indications for RhoGAM administration in Rh-negative mothers is crucial in preventing Rh sensitization and subsequent hemolytic disease of the newborn in future pregnancies. Nurses must educate clients on the importance of RhoGAM injections to ensure the best outcomes for both current and future pregnancies.
Option A) Abortion at 10 weeks' gestation: In an abortion at 10 weeks' gestation, there is a risk of fetal-maternal hemorrhage, leading to the exposure of the Rh antigen to an Rh-negative mother, necessitating RhoGAM administration.
Option B) Amniocentesis at 16 weeks' gestation: Amniocentesis can lead to the mixing of fetal and maternal blood, increasing the risk of sensitization in an Rh-negative mother. RhoGAM is required in this situation to prevent Rh sensitization.
Option C) Fetal demise at 24 weeks' gestation: In cases of fetal demise, there is a potential for fetal-maternal hemorrhage, exposing the mother to the Rh antigen. RhoGAM is administered to prevent Rh sensitization in this scenario.
Educational context: Understanding the indications for RhoGAM administration in Rh-negative mothers is crucial in preventing Rh sensitization and subsequent hemolytic disease of the newborn in future pregnancies. Nurses must educate clients on the importance of RhoGAM injections to ensure the best outcomes for both current and future pregnancies.